Elsevier

Physiology & Behavior

Volume 100, Issue 1, 26 April 2010, Pages 76-81
Physiology & Behavior

Alcohol and cardiovascular health

https://doi.org/10.1016/j.physbeh.2009.12.019Get rights and content

Abstract

The substantial medical risks of heavy alcohol drinking as well as the probable existence of a less harmful or safe drinking limit have been evident for centuries. Modern epidemiology studies suggest lowered risk of morbidity and mortality among lighter drinkers. Thus, defining “heavy” drinking as ≥ 3 standard drinks per day, the alcohol–mortality relationship is a J-curve with risk highest for heavy drinkers, lowest for light drinkers and intermediate for abstainers. A number of non-cardiovascular and cardiovascular problems contribute to the increased mortality risk of heavier drinkers. The lower risk of light drinkers is due mostly to lower risk of the most common cardiovascular condition, coronary heart disease (CHD). These disparate relationships of alcoholic drinking to various cardiovascular and non-cardiovascular conditions constitute a modern concept of alcohol and health. Increased cardiovascular risks of heavy drinking include: (1) alcoholic cardiomyopathy, (2) systemic hypertension (high blood pressure), (3) heart rhythm disturbances, and (4) hemorrhagic stroke. Lighter drinking is not clearly related to increased risk of any cardiovascular condition and, in observational studies, is related to lower risk of CHD, ischemic stroke, and diabetes mellitus. A protective hypothesis for CHD is supported by evidence for plausible biological mechanisms attributable to ethyl alcohol. International comparisons and some prospective study data suggest that wine is more protective against CHD than liquor or beer. Possible non-alcohol beneficial components in wine (especially red) support possible extra protection by wine, but a healthier pattern of drinking or more favorable risk traits in wine drinkers may be involved.

Introduction

There is a basic disparity in alcohol–health relations between effects of lighter and heavier drinking [1], [2], [3]. While it has been evident for millenia that heavy uncontrolled drinking carried major social and medical risks, it was observed that light drinking was less hazardous or that there was a safe or sensible limit for most persons. Since no amount is safe for all persons, the term “sensible” may be more appropriate. Benefit from lighter alcohol intake is a more recent concept, developing from evidence with respect to coronary heart disease and other athero-thrombotic disorders.

Disparities in relations between alcohol drinking and cardiovascular (CV) conditions make it desirable to consider several disorders separately. These include alcoholic cardiomyopathy, systemic hypertension (HTN), arrhythmias, stroke, athero-thrombotic disease — especially coronary artery disease (CAD), and heart failure (HF). A historical approach is instructive because of previous interpretive pitfalls. In this article an operational definition of “moderate” and “heavy” drinking is based upon the level of drinking in several epidemiologic studies above which net harm is usually seen [1], [2], [3]. While the term “drink” is imprecise, this alcohol unit is used, since most persons think in terms of “drinks,” not grams of alcohol. Less than 3 drinks per day is called “light” or “moderate” drinking, and 3 or more drinks per day is called “heavy” drinking. The amount of alcohol is approximately the same in the usual drink of wine, liquor, or beer. Thus, a 4 ounce glass of table wine at 13% alcohol, 1¼ oz of distilled spirits at 40% alcohol, and 12 oz of U.S. beer at 5% alcohol all contain about 12.5–15 ml of pure ethyl alcohol.

Section snippets

Alcoholic cardiomyopathy

The word “cardiomyopathy” is variously defined, but is used here to mean heart muscle disease not due to disorders of the valves, coronary arteries, lungs, and pericardium. Sustained heavy alcohol drinking is one of several causes of “dilated cardiomyopathy,” a common type characterized by an enlarged heart with weakened contraction [4], [5]. The picture ranges from subclinical abnormalities detectable only by testing to severe illness with heart failure and substantial mortality. The condition

Hypertension

After a 1915 report of an association between heavy drinking and HTN in middle-aged French servicemen [19], it was more than 50 years before the subject received further attention. Now dozens of cross-sectional and prospective epidemiologic studies have solidly established an empiric alcohol–HTN link, and clinical experiments have confirmed this [20], [21], [22], [23]. The observation has been made in North American, European, Australian, and Japanese populations and seems independent from

Cardiac arrhythmias

An association of heavier alcohol consumption with atrial arrhythmias, typically occurring after a large meal with much alcohol, became known as the “holiday heart phenomenon” [35]. Atrial fibrillation is the commonest manifestation, and arrhythmia typically resolves with abstinence. A Kaiser Permanente study [36] compared atrial arrhythmias in 1322 persons reporting ≥ 6 drinks per day to arrhythmias in 2644 light drinkers and showed that the relative risk doubled in the heavier drinkers.

Cerebrovascular disease

Studies of alcohol and stroke have to consider complex inter-relationships of stroke, alcohol, and other cardiovascular conditions [2], [3], [5], [39], [40]. Systemic HTN is an important risk factor for all types of stroke and could be an intermediary between heavy alcohol drinking and increased stroke risk. Anti-thrombotic effects of alcohol might increase hemorrhagic while lowering ischemic stroke risk. Blood lipid effects of alcohol (see CHD discussion below) might favorably affect ischemic

Epidemiology

As the cause of a majority of all cardiovascular deaths CAD dominates statistics for cardiovascular mortality. Atherosclerosis in epicardial vessels is the usual basis of CAD. Clot formation plays a critical role in acute myocardial infarction or arrhythmia death. Well-known, probably causal, risk factors include cigarette smoking, HTN, diabetes mellitus, elevated low-density lipoprotein (LDL) cholesterol, and diminished high-density lipoprotein (HDL) cholesterol.

In 1796 Heberden's described

Alcohol and CAD: a causal association?

Without a randomized controlled trial with CAD outcome data, uncertainty remains about the causal nature of the inverse alcohol–CAD association, because potential confounding cannot be completely ruled out. Skeptics about benefit from lighter drinking have appropriately emphasized possible flaws in methodology that might spuriously produce apparent benefit of moderate drinking. These might operate either via increased risk of “sick quitters” or reduced risk of “healthy drinkers.” Although less

Heart failure (HF)

The incidence of this non-specific syndrome has increased, probably because of a growing proportion of older persons in the population and because of increasing survival of heart disease patients to the stage of advanced disease. Usually, multiple risk factors rather than a unitary cause are involved. While CAD is believed to be involved in a majority of cases in developed countries, other frequently underlying conditions include HTN, valvular disease, cardiomyopathies (including alcoholic),

Conclusion and advice to patients

Table 2 summarizes the disparate alcohol–CV relations, emphasizing the basic differences between favorable relations of light–moderate drinking and unfavorable relations of heavier drinking. Advice about health effects of alcohol drinking needs to be individualized according to the specific medical history and risks of any concerned person [2], [3], [83], [84]. For example, the increased risk of breast cancer in moderate female drinkers [85] outweighs any cardiovascular benefit in young (< 50 

References (85)

  • H.W. Gruchow et al.

    Effects of drinking patterns on the relationship between alcohol and coronary occlusion

    Atherosclerosis

    (1982)
  • E. Della Valle et al.

    Drinking habits and health in Northern Italian and American men

    Nutr Metab Cardiovasc Dis

    (2009)
  • M. Trevisan et al.

    Risk Factor and Life Expectancy Research Group. Drinking pattern and mortality: the Italian Risk Factor and Life Expectancy pooling project

    Ann Epidemiol

    (2001)
  • M.H. Criqui et al.

    Does diet or alcohol explain the French paradox?

    Lancet

    (1994)
  • S. Renaud et al.

    Wine, alcohol, platelets, and the French paradox for coronary heart disease

    Lancet

    (1992)
  • E.N. Frankel et al.

    Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine

    Lancet

    (1993)
  • C.R. Pace-Asciak et al.

    The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease

    Clin Chim Acta

    (1995)
  • D. Aguilar et al.

    Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction

    J Am Coll Cardiol

    (2004)
  • A.L. Klatsky et al.

    Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease

    Am J Cardiol

    (2005)
  • A.L. Klatsky

    Drink to your health?

    Sci Am

    (2006)
  • R.A. Kloner et al.

    To drink or not to drink? That is the question

    Circulation

    (2007)
  • A.L. Klatsky

    Alcohol and cardiovascular diseases: a historical overview

    Ann N Y Acad Sci

    (2002)
  • O. Böllinger

    Ueber die Haussigkeit und Ursachen der idiopathischen Herzhypertrophie in München

    Disch Med Wochenschr (Stuttgart)

    (1884)
  • G. Steell
  • J. MacKenzie
  • W.C. Aalsmeer et al.

    Herz und Kreislauf bei der Beri-Beri Krankheit

    Wein Arch Inn Med

    (1929)
  • C.S. Keefer

    The beriberi heart

    Arch Int Med

    (1930)
  • R.B. Blacket et al.

    Haemodynamic studies in high output beri-beri

    Br Heart J

    (1960)
  • P.J. Richardson et al.

    Alcohol and the myocardium

  • J.G. Demakis et al.

    The natural course of alcoholic cardiomyopathy

    Ann Intern Med

    (1974)
  • A. Urbano-Marquez et al.

    Effects of alcohol on cardiac and skeletal muscle

    N Engl J Med

    (1989)
  • A. Urbano-Márquez et al.

    Effects of alcohol on skeletal and cardiac muscle

    Muscle Nerve

    (2004)
  • E.A. Laposata et al.

    Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse

    Science

    (1986)
  • C. Lian

    L'alcoholisme cause d'hypertension arterielle

    Bull Acad Med (Paris)

    (1915)
  • A.L. Klatsky et al.

    Alcohol and hypertension

  • L. Kodavali et al.

    Alcohol and its relationship to blood pressure

    Curr Hypertens Rep

    (2006)
  • A.V. Chobanian et al.

    The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report

    JAMA

    (2003)
  • H.D. Sesso et al.

    Alcohol consumption and the risk of hypertension in women and men

    Hypertension

    (2008)
  • A.L. Klatsky et al.

    Alcohol consumption and blood pressure

    N Engl J Med

    (1977)
  • A.L. Klatsky et al.

    The relationships of alcoholic beverage use and other traits to blood pressure: a new Kaiser Permanente study

    Circulation

    (1986)
  • I.B. Puddey et al.

    Evidence of a direct effect of alcohol consumption on blood pressure in normotensive men: a randomized controlled trial

    Hypertension

    (1985)
  • M. Parker et al.

    A 2-way factorial study of alcohol and salt restriction in treated hypertensive men

    Hypertension

    (1990)
  • Cited by (80)

    • Alcohol – The myth of cardiovascular protection

      2022, Clinical Nutrition
      Citation Excerpt :

      Our results support these findings in continuous analysis by observing a positive relationship with ischaemic heart disease when consuming more than 14 units alcohol per week when captured from beer/cider and spirits. Evidence for CV protection versus harm attributable to alcohol comes mostly from in vitro [28,29], in vivo [30] and observational studies [4,31–33]. Regarding protection, current evidence tilts the balance towards polyphenols rather than alcohol [28,29,34,35] as investigators also observe CV protection from alcohol-free wine [33,36,37].

    • Effects of cocaine and/or heroin use on resting cardiovascular function

      2021, International Journal of Cardiology: Cardiovascular Risk and Prevention
      Citation Excerpt :

      Studies have found that race, sex, and age positively associate with BP, HR, and QTc duration whereas obesity positively associate with BP, HR, QRS complex duration, QTc, PR interval, and P-wave duration. Further, cocaine and heroin use typically co-occur with other substance use [3,30], especially tobacco, alcohol and cannabis, each of which has unique impacts on the cardiovascular system [4,31–36]. Moreover, these drugs can modulate effects of cocaine and/or heroin.

    • Alcohol: The role in nutrition and health

      2020, Present Knowledge in Nutrition: Clinical and Applied Topics in Nutrition
    • Alcohol: Pharmacokinetics, health benefits with moderate consumption and toxicity

      2019, Critical Issues in Alcohol and Drugs of Abuse Testing
    View all citing articles on Scopus

    Purdue University Ingestive Behavior Research Center Symposium, “Impact of Beverages on Energy Balance and Health,” September 17–19, 2009, Indianapolis, Indiana.

    View full text